南美洲疟疾治疗市场预测至 2028 年 – COVID-19 影响和区域分析 – 按治疗(处方药、疫苗、诊断测试等)、药物类型(品牌和仿制药)、给药途径(口服和口服)注射剂和静脉注射)、分销渠道(直接招标、医院药房、零售药房、在线药房等)和最终用户(医院、专科诊所、家庭护理等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 154    |    Report Code: BMIRE00027975    |    Category: Life Sciences

South America Malaria Treatment Market

南美疟疾治疗市场预计将从2022年的7179万美元增长到2028年的9853万美元。预计2022年至2028年的复合年增长率为5.4%。< /strong>

 

快速诊断测试正在推动南美疟疾治疗市场

 

疟疾 RDT 可以提高疾病管理的质量。事实证明,对于在资源匮乏地区实施的公共卫生计划来说,快速诊断治疗是非常经济实惠且有效的。 RDT 广泛应用于显微镜服务有限的偏远地区。因此,针对疟疾的 RDT 需求迅速增加。已经开发了几种 RDT 来测试南美洲血液中是否存在疟疾寄生虫。在低传播地区识别并成功治疗疟疾对于减少传播和彻底消除该疾病至关重要。许多公司致力于开发各种高灵敏度的 RDT。因此,不断增长的快速诊断测试预计将推动南美洲整个地区疟疾治疗市场的增长。

 

南美洲疟疾治疗市场概况

  ;

南美洲疟疾治疗市场分为巴西、阿根廷和南美洲其他地区。在预测期内,巴西占据了市场的很大份额。疟疾一直是巴西的一个主要公共卫生问题。巴西疟疾的早期历史及其控制措施受到非洲人作为奴隶的被迫迁移和欧洲人的殖民化的推动。这些移民将疟疾带到了巴西的不同地区。在巴西,疟疾是由三种疟原虫引起的。间日疟原虫(占登记病例的 83.7%)、恶性疟原虫(占病例的 16.3%)和三日疟原虫(占病例的一小部分)。巴西政府推出国家消除疟疾计划,计划到2025年将当地疟疾病例减少到6.8万例以下,到2030年将死亡人数减少到零,并在2035年在巴西消除疟疾。巴西是一个国家亚马逊雨林所在地,大多数疟疾病例都来自那里。巴西约 99.9% 的传播发生在亚马逊地区,80% 发生在 33 个城市。

2021 年,报告病例超过 137.8 例。巴西政府正在向城市和州投资治疗、害虫防治和技术支持,同时还培训人员。消除计划将通过巴西统一卫生系统开展工作,以免费诊断和治疗、诊断和广泛覆盖治疗的分散行动为基础,并利用在线信息系统、多部门伙伴关系和研究网络。 2019年10月30日,葛兰素史克巴西公司和MMV宣布,巴西卫生监管局(AVINSA)已授予单剂量他非诺喹的上市许可,用于治疗16岁和16岁间日疟原虫疟疾患者。对于因急性间日疟原虫感染而接受氯喹治疗的老年人。葛兰素史克巴西制药部门总裁何塞·卡洛斯·费尔纳表示,他非诺喹在该国的批准是对抗疟疾等被忽视疾病的重要一步。这将增加巴西对疟疾治疗的需求并有助于根除这种疾病。因此,巴西政府不断增长的技术支持可以推动市场的增长。

 

南美疟疾治疗市场收入到 2028 年的预测(百万美元)

南美洲

 疟疾治疗市场细分

 

南美疟疾治疗市场是根据治疗、药物类型、给药途径、分销渠道、最终用户和国家进行细分。   

 

根据治疗,南美疟疾治疗市场分为处方药、疫苗、诊断测试等。诊断测试细分市场在2022年占据最大的市场份额。处方药细分市场进一步分为磷酸氯喹、基于青蒿素的联合疗法(ACT)、阿托伐醌-氯胍、硫酸奎宁(夸喹)与多西环素、磷酸伯氨喹等。

 

根据药物类型,南美疟疾治疗市场分为品牌药和仿制药。到 2022 年,仿制药细分市场将占据更大的市场份额。

 

根据给药途径,南美疟疾治疗市场分为口服药物和肠胃外注射剂静脉。 2022年口服细分市场将占据更大的市场份额。

 

根据分销渠道,南美疟疾治疗市场细分为直接招标、医院药房、零售药房、网上药房等。 2022年,直接招标细分市场占据最大市场份额。

 

根据最终用户,南美疟疾治疗市场分为医院、专科诊所、家庭护理等。到 2022 年,医院细分市场占据最大的市场份额。

 

按国家划分,南美疟疾治疗市场已分为巴西、阿根廷和南美洲其他地区。我们的区域分析表明,南美洲其他地区将在 2022 年占据市场主导地位。 > 

AdvaCare Pharma USA LLC、Cipla Ltd、GSK Plc、Lupin Ltd、Novartis AG、Sanofi SA、Sun Pharmaceutical Industries Ltd、Viatris Inc 和 Zydus Healthcare Ltd 均属于领先公司进军南美疟疾治疗市场。



South America Malaria Treatment Strategic Insights

Strategic insights for South America Malaria Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-america-malaria-treatment-market-strategic-framework.webp
Get more information on this report

South America Malaria Treatment Report Scope

Report Attribute Details
Market size in 2022 US$ 71.79 Million
Market Size by 2028 US$ 98.53 Million
Global CAGR (2022 - 2028) 5.4%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 治疗
  • 处方药
  • 疫苗
  • 诊断测试
By 药品类型
  • 品牌药和仿制药
By 给药途径
  • 口服
  • 肠外和静脉注射
By 分销渠道
  • 直接招标
  • 医院药房
  • 零售药房
  • 网上药房
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • AdvaCare Pharma USA LLC
  • Cipla Ltd
  • GSK Plc
  • Lupin Ltd
  • Novartis AG
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd
  • Viatris Inc
  • Zydus Healthcare Ltd
  • Get more information on this report

    South America Malaria Treatment Regional Insights

    The regional scope of South America Malaria Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-america-malaria-treatment-market-geography.webp
    Get more information on this report

    The List of Companies - South America Malaria Treatment Market

    1. AdvaCare Pharma USA LLC
    2. Cipla Ltd
    3. GSK Plc
    4. Lupin Ltd
    5. Novartis AG    
    6. Sanofi SA
    7. Sun Pharmaceutical Industries Ltd
    8. Viatris Inc    
    9. Zydus Healthcare Ltd
    Frequently Asked Questions
    How big is the South America Malaria Treatment Market?

    The South America Malaria Treatment Market is valued at US$ 71.79 Million in 2022, it is projected to reach US$ 98.53 Million by 2028.

    What is the CAGR for South America Malaria Treatment Market by (2022 - 2028)?

    As per our report South America Malaria Treatment Market, the market size is valued at US$ 71.79 Million in 2022, projecting it to reach US$ 98.53 Million by 2028. This translates to a CAGR of approximately 5.4% during the forecast period.

    What segments are covered in this report?

    The South America Malaria Treatment Market report typically cover these key segments-

  • 治疗 (处方药, 疫苗, 诊断测试)
  • 药品类型 (品牌药和仿制药)
  • 给药途径 (口服, 肠外和静脉注射)
  • What is the historic period, base year, and forecast period taken for South America Malaria Treatment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Malaria Treatment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in South America Malaria Treatment Market?

    The South America Malaria Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • AdvaCare Pharma USA LLC
  • Cipla Ltd
  • GSK Plc
  • Lupin Ltd
  • Novartis AG
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd
  • Viatris Inc
  • Zydus Healthcare Ltd
  • Who should buy this report?

    The South America Malaria Treatment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America Malaria Treatment Market value chain can benefit from the information contained in a comprehensive market report.